On the other hand, its pivotal role in the IRF5 pathway and subsequent predisposition to SLE, urges the design of compounds that can mechanistically prevent the recruitment of the adaptor protein TASL by PHT1 and consequently IFN-I production. Here, TASL is linked to systemic lupus erythematosus.